iCardio.ai Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 14

iCardio.ai General Information

Description

Developer of deep-learning echo tools designed for echocardiographic analysis. The company's models are based on segmentation, classification, regression analysis, and artificial intelligence for the interpretation of ultrasound imaging, with a focus on echocardiograms, enabling ultrasound companies to research and development of AI algorithms and offering a custom application for the interpretation of ultrasound imaging.

Contact Information

Website
www.icardio.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9415 Oakmore Road
  • Los Angeles, CA 90035
  • United States
+1 (310)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 9415 Oakmore Road
  • Los Angeles, CA 90035
  • United States
+1 (310)

iCardio.ai Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

iCardio.ai Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 07-Apr-2026 Completed Generating Revenue
10. Grant 15-Mar-2025 Completed Generating Revenue
9. Accelerator/Incubator 01-Jan-2025 Completed Generating Revenue
8. Later Stage VC 01-Dec-2024 Completed Generating Revenue
7. Accelerator/Incubator 01-Aug-2024 Completed Generating Revenue
6. Accelerator/Incubator 05-Dec-2023 Completed Generating Revenue
5. Accelerator/Incubator 16-May-2023 Completed Generating Revenue
4. Accelerator/Incubator 20-Oct-2022 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2022 $1M Completed Generating Revenue
2. Accelerator/Incubator 01-Jun-2021 $1M $1M Completed Generating Revenue
To view iCardio.ai’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

iCardio.ai Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of deep-learning echo tools designed for echocardiographic analysis. The company's models are based on segment
Diagnostic Equipment
Los Angeles, CA
20 As of 2026

Oxford, United Kingdom
 

San Mateo, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

iCardio.ai Competitors (3)

One of iCardio.ai’s 3 competitors is Ultromics, a Venture Capital-Backed company based in Oxford, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ultromics Venture Capital-Backed Oxford, United Kingdom
Caption Care Formerly VC-backed San Mateo, CA
Us2.ai Venture Capital-Backed Singapore, Singapore
You’re viewing 3 of 3 competitors. Get the full list »

iCardio.ai Patents

iCardio.ai Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12725706-B2 Methods, systems, apparatuses, and devices for facilitating a diagnosis of pathologies using a machine learning model Active 26-Jan-2023
US-20240257967-A1 Methods, systems, apparatuses, and devices for facilitating a diagnosis of pathologies using a machine learning model Active 26-Jan-2023

iCardio.ai Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

iCardio.ai Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
100KM Ventures Venture Capital Minority
Boomerang Ventures Venture Capital Minority
Cedars Sinai Health Ventures Corporate Venture Capital Minority
Cove Fund Venture Capital Minority
The Roddenberry Foundation Corporation
You’re viewing 5 of 14 investors. Get the full list »

iCardio.ai FAQs

  • When was iCardio.ai founded?

    iCardio.ai was founded in 2018.

  • Where is iCardio.ai headquartered?

    iCardio.ai is headquartered in Los Angeles, CA.

  • What is the size of iCardio.ai?

    iCardio.ai has 20 total employees.

  • What industry is iCardio.ai in?

    iCardio.ai’s primary industry is Diagnostic Equipment.

  • Is iCardio.ai a private or public company?

    iCardio.ai is a Private company.

  • What is iCardio.ai’s current revenue?

    The current revenue for iCardio.ai is .

  • How much funding has iCardio.ai raised over time?

    iCardio.ai has raised $1.37M.

  • Who are iCardio.ai’s investors?

    100KM Ventures, Boomerang Ventures, Cedars Sinai Health Ventures, Cove Fund, and The Roddenberry Foundation are 5 of 14 investors who have invested in iCardio.ai.

  • Who are iCardio.ai’s competitors?

    Ultromics, Caption Care, and Us2.ai are competitors of iCardio.ai.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process